Mar 1, 2017

Therapeutic potential of adipose-derived stem cells and macrophages for ischemic skeletal muscle repair

Regenerative Medicine
Viktoriya RybalkoLaura J Suggs


Progressive ischemia due to peripheral artery disease causes muscle damage and reduced strength of the lower extremities. Autologous cell therapy is an attractive treatment to restore perfusion and improve muscle function. Adipose-derived stem cells (ASCs) have therapeutic potential in tissue repair, including polarizing effects on macrophages (MPs). Co-culture systems of ASCs and MPs were analyzed for gene and protein expression modifications in ASC-conditioned MPs. Co-transplantation of MPs/ASCs in vivo led to improved skeletal muscle regeneration in a mouse model of peripheral artery disease. ASCs/MPs therapy restored muscle function, increased perfusion and reduced inflammatory infiltrate. Combined MPs/ASCs cell therapy is a promising approach to restore muscle function and stimulate local angiogenesis in the ischemic limb.

  • References2
  • Citations7


  • References2
  • Citations7


Mentioned in this Paper

RPS27 protein, human
Muscle Damage
In Vivo
Fat Pad
Cell Injury
Angiogenic Process
Coculture Techniques

Related Feeds

Allogenic & Autologous Therapies

Allogenic therapies are generated in large batches from unrelated donor tissues such as bone marrow. In contrast, autologous therapies are manufactures as a single lot from the patient being treated. Here is the latest research on allogenic and autologous therapies.

CREs: Gene & Cell Therapy

Gene and cell therapy advances have shown promising outcomes for several diseases. The role of cis-regulatory elements (CREs) is crucial in the design of gene therapy vectors. Here is the latest research on CREs in gene and cell therapy.